EVIO, Inc. (OTCQB: EVIO) this morning announced that its EVIO Labs division has already exceeded last October’s testing revenues through the first half of October 2017.
EVIO, Inc. (OTCQB: EVIO) this morning announced that its EVIO Labs division has already exceeded last October’s testing revenues through the first half of October 2017.
Marijuana Company of America, Inc. (OTC: MCOA) is among those managing to shine in spite of the growing competition, successfully carving out a niche with its unique, strategic approach and distinctive business model.
Recently acquired by ABcann Global Corporation, an acquisition that came with a $26.8 million capital raise to help expand production, the company is already licensed to sell to the entire Canadian market and plans to significantly expand production to reach this goal.
Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced preclinical results in the development of INM-405 for the treatment of pain.
Going public appears to be paying off for ABcann Medicals (TSXV: ABCN), since the medical cannabis grower launched its initial public offering (IPO) on the TSX Venture Exchange.
What are the risks and opportunities for financial professionals serving cannabis industry clients? The California Cannabis Industry Symposium will explore that question August 11 at the Radisson Oakland Airport.
Cannabis Wheaton Income Corp. (TSX VENTURE:CBW) is pleased to announce the appointment of Manon Grand-Maitre to the Advisory Board of Cannabis Wheaton.
Earlier this week, Sen. Cory Booker (D-NJ) introduced legislation that would begin to end the unfair prohibition of marijuana throughout the federal government. The bill would also serve to repair the damage done to the country via prohibition.
Booker was quoted stating that “I believe the federal government should get out of the illegal marijuana business. You see what’s happening around this country right now. Eight states and the District of Columbia have moved to legalize marijuana.
Isodiol International Inc. (CSE:ISOL) (OTC:LAGBF) (Frankfurt:LB6A.F) a global cannabis innovator specializing in the development of pharmaceutical and consumer products announces unaudited July 2017 revenue numbers of its wholly owned subsidiary ISO International LLC of $1,358,787 USD .
In response to multiple media reports regarding US market participation and security regulations, and as stated in a press release dated June 19th, 2017 , Canopy Growth Corporation (TSX: WEED) wishes to reiterate its commitment to only conducting its business in jurisdictions where it is federally legal to do so.
ABcann Global Corporation (TSXV: ABCN) this morning announced the signing of a definitive subscription agreement with Cannabis Wheaton Income Corp. (TSXV: CBW).
India Globalization Capital (NYSE MKT: IGC), a first mover in the cannabis-based combination therapy space, recently announced that it is readying a line of cannabis-based medical dispensary products that target Alzheimer’s disease.
In a news release issued earlier this week, ABcann Global Corporation (ABCN:CA) announced the appointment of W. Brett Wilson to its advisory board in connection with the company’s acquisition of ABcann Medicinals Inc.
Sweeping legislation has been introduced by the Canadian government that takes aim at permitting nationwide recreational cannabis use by July 2018—a move applauded by companies that are currently licensed to produce medical marijuana in Canada or are engaged in providing services to growers.
Many patients rely on Chinese herbs for temporary control. However, ChineseInvestors.com’s (OTCQB: CIIX) current development plan includes making cannabidiol (CBD) products available online for people with epilepsy and Alzheimer’s disease.